(PubMed) Suh JH, Zhu BZ, deSzoeke E, Frei B, Hagen TM
The peptide's pharmacokinetics in dogs absorption, half-life, and clearance have not been characterized, so neither dosing frequency nor the ideal timing of administration relative to an injury is known
For both the MIPS Promoting Interoperability performance category and the Medicare Promoting Interoperability Program, we proposed to Adopt and codify at 414.1380(b)(4)(iii) and 495.24(f)(3), respectively, a measure suppression policy beginning with the CY 2026 performance period/2028 MIPS payment year and the EHR reporting period in CY 2026
The lack of clear indication for requesting ammonia testing in epilepsy patients led us to conduct this service evaluation
Prioritize rest and sleep cycles